Vasa Denticity Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Healthcare Equipment & Supplies | Market Cap: ₹673 Cr
The company aims to achieve revenue between ₹800 to ₹1200 crores over the next 5 years, indicating strong growth aspirations. The company targets a gross margin range of 27-30% medium-term, with a cautious approach not to exceed 33% to pass benefits to customers.
From Vasa Denticity Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Price
₹416
Market Cap
₹673 Cr
P/E Ratio
62.4
Revenue Rank
Margin Rank
How does Vasa Denticity Ltd rank in Healthcare Equipment & Supplies?
Compare Vasa Denticity Ltd against every Healthcare Equipment & Supplies company this quarter on revenue, margins and earnings-call signals.
Vasa Denticity Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹72 Cr, net profit ₹1 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 3- →The company aims to achieve revenue between ₹800 to ₹1200 crores over the next 5 years, indicating strong growth aspirations.
- →Revenue growth targets for FY27 are around ₹500-600 crores and ₹800-1200 crores for FY28, reflecting ambitious scaling plans.
- →Growth is expected to be driven primarily by increasing average order value and repeat purchases rather than acquiring new customers.
- →There is a focus on increasing order frequency and customer wallet share through strategies like discounts on multiple items and tech solutions offering incentives.
- →New business lines like digital dentistry equipment (intraoral scanners, 3D printers) are becoming significant growth drivers.
- →Organic growth is prioritized over acquisitions currently, with inorganic opportunities considered only if organic growth plateaus.
- →Expansion plans include extending same-day or next-day delivery beyond tier-1 cities to tier 2 and 3 cities to drive volumes.
- →The company anticipates sustained or improved gross margins around 27-33%, balancing growth with fair pricing.
📈 Profitability & Margins
Rank 2- →The company targets a gross margin range of 27-30% medium-term, with a cautious approach not to exceed 33% to pass benefits to customers.
- →Revenue growth is expected to continue at a rate similar to the first quarter's year-on-year growth, led by increasing order frequency and average order value.
- →Focus on operational efficiencies (e.g., automation, optimized warehousing) aims to reduce cost-to-serve per order, improving operating margins.
- →New business lines like digital dentistry equipment are gaining traction, offering deeper client relationships and additional revenue streams.
- →Non-product revenue streams (e.g., education webinars, demos) are expected to contribute to margin expansion beyond 33%.
- →Hiring senior leadership and strengthening teams to improve execution and scaling.
- →No explicit formal guidance for FY27/28 revenues but long-term targets range from ₹800–1200 crores in five years.
- →Overall, disciplined execution with emphasis on sustainable, profitable growth and improved operational control.
🏗️ Capital Expenditure Plans
Yes- →The company is focusing on building control through in-house brands to ensure quality, pricing, and product availability, which involves capital and attention investment in these portfolios.
- →Expansion into digital dentistry division (intraoral scanners, milling machines, 3D printers, imaging products) is underway and is no longer an experiment, indicating ongoing strategic investment in this segment.
- →Inventory management and supply chain improvements are being made, including forward deployment and demand forecasting to reduce stockouts and improve delivery times, implying operational capital investment.
- →The company is optimizing warehousing and logistics, with initiatives like Insta Dent for same-day/next-day delivery, requiring investment in regional warehouses.
- →Hiring senior leadership and building the right management team, including VP marketing and supply chain, are part of their strategic focus on people and operational capability.
- →No current plans for acquisitions, focusing on organic growth and internal capacity-building first.
💰 Fundraising & Capital Structure
No- →There is no mention of any current or immediate plans for new fundraising through debt or equity.
- →The company is focusing on organic growth and improving its core business rather than acquisitions or external funding.
- →They have consciously chosen not to pursue acquisitions this year and are instead concentrating on strategy and strengthening their team.
- →The management indicated that if organic growth in a particular category becomes difficult in the future, they might consider inorganic opportunities like buyouts, but currently, there is no such plan.
- →Cash on hand will be used as working capital for the company, not for external fundraising (Page 21).
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Vasa Denticity Ltd Q1 FY27 results?
The company aims to achieve revenue between ₹800 to ₹1200 crores over the next 5 years, indicating strong growth aspirations. The company targets a gross margin range of 27-30% medium-term, with a cautious approach not to exceed 33% to pass benefits to customers.
What is Vasa Denticity Ltd share price analysis?
Vasa Denticity Ltd currently shows a below-average growth signal. The stock trades at a P/E of 62.4 with a market cap of ₹673 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vasa Denticity Ltd planning capital expenditure?
The company is focusing on building control through in-house brands to ensure quality, pricing, and product availability, which involves capital and attention investment in these portfolios.
Keep Vasa Denticity Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.